stage 4 lymphoma | Life expectancy for stage 3 Lymph Node cancer patient

Life expectancy for stage 3 Lymph Node cancer patient

The lymphatic system includes a network of vessels that carry a liquid called lymph through the body. Lymph contains lymphocytes, or white blood cells, cells of the immune system fighting the disease. Lymph nodes filter lymph and can become cancerous. There are about 35 types of lymphocytes which may be involved in lymph nodes (Lymphoma) cancers. According to the Emedicinehealth site, lymphoma is the most common type of blood cancer in the United States.

Types

Lymphoma prognosis varies depending on the type, age at diagnosis, and previous health problems. Lymphoma can be hodgkiniens or not hodgkiniens and it can be indolent or aggressive. The difference between Hodgkin's disease and Lymphoma not hodgkiniens it is in the specific lymphocyte (white blood cells), it affects. The presence of a Reed-Sternberg cell, a specific type of white blood cell abnormalities, indicates the Hodgkin's lymphoma. If the Reed-Sternberg cell is not present, the lymphoma is the variety of non Hodgkin, according to the Mayo Clinic. Indolent lymphoma is of low grade, which means that it is easier to treat and slow. Aggressive lymphoma spreads quickly and can progress quickly from step 1 to step 4. Determine your variety of lymphoma is the first step in determining your expected life expectancy.

Stage 3 Lymphoma

Stage 3 lymphoma is the last stage of the disease, when it reaches the internal organs, bone marrow and blood. On average, more the stage of lymphoma, better are the chances of survival. Stage 3 Lymphoma patients who show no other symptoms (such as fever, night sweats and weight loss) have a better prognosis than those who, according to the Lymphoma news site.

Prognosis tools

According to the American Cancer Society, there are several factors to consider during a prognosis of life expectancy. In addition to the stage of the disease, other important factors include: age; If the cancer is in the organs outside the lymphatic system; how a person can perform daily activities; and blood serum of lactate dehydrogenase (LDH) levels, which will rise quickly when the tumors are fast-growing. Based on these criteria, the doctors to assess the survival rate for each risk group: low, intermediate and high.

State of the 3 non Hodgkin Lymphoma

The survival rate at five years for patients with non-Hodgkin Lymphoma in the high-risk category is 53 percent, according to the American Cancer Society. The survival rate for ten years for this group is 36 percent. The average five-year survival rate is 63 percent. The average ten-year survival rate is 51 per cent.

Step 3 of Hodgkin's disease

Hodgkin's lymphoma is the rarer of the two forms. The average five-year survival rate is 85 percent, while the average 10-year survival rate is 81 percent. As develop therapies, life expectancy is getting longer. It was a significant improvement in results since the 1970s. Today 92 percent of patients with Hodgkin's lymphoma survive for at least one year after diagnosis.